Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD

References

• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• LoganathanRSStoverDEShiWVenkatramanEPrevalence of COPD in women compared to men around the time of diagnosis of primary lung cancerChest200612951305131216685023
   PubMed Web of Science ®Google Scholar
• CongletonJMuersMFThe incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapyRespir Med19958942912967597269
   PubMed Web of Science ®Google Scholar
• KiriVASorianoJVisickGFabbriLRecent trends in lung cancer and its association with COPD: an analysis using the UK GP Research DatabasePrim Care Respir J2010191576119756330
   PubMedGoogle Scholar
• WangCXuJYangLPrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyLancet2018391101311706171729650248
   PubMed Web of Science ®Google Scholar
• ManninoDMAguayoSMPettyTLReddSCLow lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-upArch Intern Med2003163121475148012824098
   PubMedGoogle Scholar
• QinJLiGZhouJCharacteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decisionInt J Chron Obstruct Pulmon Dis201611Issue 11515152027445471
   PubMed Web of Science ®Google Scholar
• EttingerDSWoodDEAkerleyWNCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4. 2016J Natl Compr Canc Netw201614325526426957612
   PubMed Web of Science ®Google Scholar
• OmoteNHashimotoNMoriseMImpact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapyInt J Chron Obstruct Pulmon Dis2017123541354729270008
   PubMed Web of Science ®Google Scholar
• IzquierdoJLResanoPEl HachemAGrazianiDAlmonacidCSánchezIMImpact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitorsInt J Chron Obstruct Pulmon Dis201491053105825336937
   PubMed Web of Science ®Google Scholar
• JonesPWAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
   PubMed Web of Science ®Google Scholar
• CruzJMarquesAJácomeCGabrielRFigueiredoDGlobal Functioning of COPD Patients With and Without Functional Balance Impairment: An Exploratory Analysis Based on the ICF FrameworkCOPD201512220721625093384
   PubMedGoogle Scholar
• NederJAO’DonnellCDCoryJVentilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPDCOPD2015123252259
   Google Scholar
• PutchaNDrummondMBWiseRAHanselNNComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementSemin Respir Crit Care Med201536457559126238643
   PubMed Web of Science ®Google Scholar
• MörthCValachisASingle-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature-based meta-analysis of randomized studiesLung Cancer201484320921424702946
   PubMed Web of Science ®Google Scholar
• de SanctisATailladeLVignotSPulmonary toxicity related to systemic treatment of nonsmall cell lung cancerCancer2011117143069308021283982
   PubMed Web of Science ®Google Scholar
• BeasleyMBBrambillaETravisWDThe 2004 World Health Organization classification of lung tumorsSemin Roentgenol2005402909715898407
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet]Global strategy for the diagnosis, management and prevention of COPD, global initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: https://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed July 17, 2018
   Google Scholar
• KawaiTYakumaruKSuzukiMKageyamaKDiffuse interstitial pulmonary fibrosis and lung cancerActa Pathol Jpn198737111193033984
   PubMedGoogle Scholar
• WatanabeNTaniguchiHKondohYEfficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosisRespiration201385432633123171837
   PubMed Web of Science ®Google Scholar
• MinegishiYSudohJKuribayasiHThe safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasLung Cancer2011711707420493578
   PubMed Web of Science ®Google Scholar
• MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
   PubMed Web of Science ®Google Scholar
• FidiasPMDakhilSRLyssAPPhase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancerJ Clin Oncol200927459159819075278
   PubMed Web of Science ®Google Scholar
• Paz-AresLGde MarinisFDediuMPARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerJ Clin Oncol201331232895290223835707
   PubMed Web of Science ®Google Scholar
• FossellaFPereiraJRvon PawelJRandomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study groupJ Clin Oncol200321163016302412837811
   PubMed Web of Science ®Google Scholar
• ScagliottiGVParikhPvon PawelJPhase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerJ Clin Oncol200826213543355118506025
   PubMed Web of Science ®Google Scholar
• HirschFRSpreaficoANovelloSWoodMDSimmsLPapottiMThe prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewJ Thorac Oncol20083121468148119057275
   PubMed Web of Science ®Google Scholar
• WangMLiGYangZUncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancerOncotarget2017858083809428042952
   PubMedGoogle Scholar
• LilenbaumRVillaflorVMLangerCSingle-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trialsJ Thorac Oncol20094786987419487960
   PubMed Web of Science ®Google Scholar
• ChoiKJChaSIShinKMPrevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary diseaseRespiration201385320320922338649
   PubMed Web of Science ®Google Scholar
• WarkPAToozeMPowellHParsonsKViral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmissionRespirology2013186996100223600594
   PubMed Web of Science ®Google Scholar
• YamanashiKMarumoSShojiTThe relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary diseaseGen Thorac Cardiovasc Surg2015631265265926419246
   PubMedGoogle Scholar
• TakegaharaKUsudaJInoueTIbiTSatoAPreoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary diseaseGen Thorac Cardiovasc Surg201765738839128281043
   PubMed Web of Science ®Google Scholar
• ElsayadKSamhouriLScobioalaSHaverkampUEichHTIs tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?J Cancer Res Clin Oncol201814461165117129623466
   PubMed Web of Science ®Google Scholar
• KäsmannLNiyaziMBlanckOPredictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer: A systematic reviewStrahlenther Onkol20181942799029030654
   PubMed Web of Science ®Google Scholar
• AntoniaSJVillegasADanielDDurvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerN Engl J Med2017377201919192928885881
   PubMed Web of Science ®Google Scholar